Obesity should no longer be seen as the result of individuals’ habits but recognized as a chronic illness, Novo Nordisk Korea said Thursday.

The Korean offshoot of the Danish pharmaceutical giant hosted an in-house contest Tuesday to come up with a Korean name for its “Rethink Obesity” campaign, to raise awareness of obesity as a chronic disease. The first prize went to “Biman Jaego,” a literal translation of Rethink Obesity.

Rethink Obesity is a global campaign aimed at medical professionals seeking to rectify the social perception of obesity and the importance of obesity management, the company said.

“Obesity is not just a problem of individual laziness or overeating. We need to raise awareness of obesity as a chronic illness stemming from various elements,” said Rana Azfar Zafar, the general manager of the Korean branch.

“Novo Nordisk Korea, with the recent approval of the world’s first GLP-1 obesity treatment Saxenda, will continue to provide the correct information and education of obesity to domestic health care providers and the obese so they can lead a healthy life,” the official added.

Since 2015, 50 countries have observed October 11 as World Obesity Day holding a variety of activities to prevent, reduce, and treat obesity, the company said.